| Identification | More | [Name]
Hecogenin | [CAS]
467-55-0 | [Synonyms]
25R,5ALPHA-SPIROSTAN-3BETA-OL-12-ONE
3BETA-HYDROXY-5ALPHA-SPIROSTAN-12-ONE
5-ALPHA, 20-ALPHA, 22-ALPHA, 25D-SPIROSTAN-3-BETA-OL-12-ONE
5ALPHA-SPIROSTAN-3BETA-OL-12-ONE
HECOGENIN
(25R)-5-Spirostan-3-ol-12-one
Hecoginin
HECOGENIN 98.0% BY HPLC
(3,5,25R)-3-Hydroxysiprostan-1
(3,5,25R)-3-Hydroxysiprostan-12-one
HECOGENIN (3B-HYDROXY-5A-SPIROSTAN-12-ONE)
3β-Hydroxy-5α-spirostan-12-one, 5α-Spirostan-3β-ol-12-one
12-Oxotigogenin
3-b-Hydroxy-5-a-spirostan-12-one
(25R)-3β-Hydroxy-5α-spirostan-12-one | [EINECS(EC#)]
207-392-4 | [Molecular Formula]
C27H42O4 | [MDL Number]
MFCD00067285 | [Molecular Weight]
430.62 | [MOL File]
467-55-0.mol |
| Chemical Properties | Back Directory | [Melting point ]
268°C | [alpha ]
7.2 º (c=0.8 g/100ml, CHCl3) | [Boiling point ]
464.85°C (rough estimate) | [density ]
1.0040 (rough estimate) | [refractive index ]
1.4840 (estimate) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
15.10±0.70(Predicted) | [color ]
White to Off-White | [Merck ]
4622 | [CAS DataBase Reference]
467-55-0(CAS DataBase Reference) |
| Hazard Information | Back Directory | [Uses]
antiinflammatory | [Uses]
Hecogenin, is a sapogenin present in the leaves of species from the Agave genus, possessing wide spectrum of pharmacology activities, such as having antinociceptive properties. | [Definition]
ChEBI:Hecogenin is a triterpenoid. | [in vivo]
Hecogenin (3.1-90 mg/kg; oral administration; for 15 hours; male Swiss mice) acutely administered, before ethanol, exhibits a potent gastroprotective effect. The Hecogenin pretreatment normalizes GSH levels and significantly reduces lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Hecogenin also decreases MPO release and significantly protects the gastric mucosa[1]. | Animal Model: | Male Swiss mice (20-30 g) with ethanol[1] | | Dosage: | 3.1 mg/kg, 7.5 mg/kg, 15 mg/kg, 30 mg/kg, 60 mg/kg and 90 mg/kg | | Administration: | Oral administration; for 15 hours | | Result: | Normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. Decreased MPO release and significantly protected the gastric mucosa.
|
| [storage]
Store at -20°C | [Purification Methods]
The saponin (~35 mg) in EtOAc is chromatographed on Al2O3 and eluted with *C6H6/Et2O, and the residue on evaporation is recrystallised from Me2CO. [Mazur et al. J Am Chem Soc 82 5889 1960, Marker et al. J Am Chem Soc 69 2167 1947, Beilstein 19 III/IV 2581.] |
|
|